Tredegar (TG) Q1 2026 earnings summary

Executive summary

• Net income from continuing operations rose to $5.1 million ($0.15 per diluted share) in Q1 2026 from $0.7 million ($0.02 per diluted share) in Q1 2025, driven by higher sales and lower SG&A and interest expenses.

• EBITDA from ongoing operations increased for Aluminum Extrusions but declined for High Performance Films year-over-year; consolidated EBITDA from ongoing operations was $11.7 million in Q1 2026, up slightly from $11.5 million in Q1 2025.

• Performance was primarily driven by Aluminum Extrusions, which offset softness in High Performance Films.

• The company completed the sale of its flexible packaging films business (Terphane) in late 2024; all historical results for Terphane are now presented as discontinued operations.

Financial highlights

• Q1 2026 sales were $186.5 million, up from $164.7 million in Q1 2025, a 13.2% increase.

• Gross profit margin declined to 12.6% from 14.3% year-over-year.

• SG&A and R&D expenses as a percentage of sales fell to 8.9% from 12.6% due to lower professional fees and compensation.

• Net debt stood at $30.7 million as of March 31, 2026, up from $28.4 million at year-end 2025.

• Net cash provided by operating activities was $2.0 million, compared to net cash used of $5.0 million in Q1 2025.

Outlook and guidance

• Capital expenditures for 2026 are projected at $20 million for Aluminum Extrusions and $2 million for High Performance Films.

• The company expects capital spending to increase and align with depreciation and amortization, supporting maintenance and efficiency initiatives.

• Ongoing focus on operational excellence, productivity improvements, and cost reduction to drive long-term value.

• Management believes current liquidity and borrowing capacity are sufficient for at least the next 12 months.